fda glp-1 compounding warning september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our fda warning letter hims compounded

Interstitial cells of Cajal in diabetic gastroenteropathy

By understanding these distinctions, you can choose the form that delivers maximum health benefits for detoxification, immune support, and cellular protection

Newer research is looking at how the anti-inflammatory effects of these drugs might be helpful to people living with neurodegenerative diseases, such as Alzheimers and Parkinsons

How long should you run a peptide stack

These medications are particularly effective for women undergoing life transitions such as postpartum recovery or menopause, where hormonal variations can complicate body mass management